1. 独立行政法人医薬品医療機器総合機構. レセプトデータを用いた有害事象発現リス クの評価手法に関する試行調査（1）報告書. 2014.
http://www.info.pmda.go.jp/kyoten_iyaku/file/e_rece-report1405_001.pdf
（アクセス日：2014年6月6日）
2. 独立行政法人医薬品医療機器総合機構. レセプトデータを用いたアナフィラキシー に関する試行調査報告書. 2010.
http://www.info.pmda.go.jp/kyoten_iyaku/file/e_rece-report1405.pdf
（アクセス日：2014年6月6日）
3. 独立行政法人医薬品医療機器総合機構. レセプトデータを用いた有害事象発現リス クの評価手法に関する試行調査（2）報告書. 2014.
http://www.info.pmda.go.jp/kyoten_iyaku/file/e_rece-report1405_002.pdf
（アクセス日：2014年6月6日）
4. Maclure M, Fireman B, Nelson JC, Hua W, Shoaibi A, Paredes A, et al. When should case-only designs be used for safety monitoring of medical products?
Pharmacoepidemiol Drug Saf. 2012 Jan;21 Suppl 1:50-61.
5. 久保田潔. 分析疫学研究. In: 景山茂, 久保田潔, editors. 薬剤疫学の基礎と実践. 大 阪: 医薬ジャーナル社; 2010.
6. Hallas J, Bytzer P. Screening for drug related dyspepsia: an analysis of prescription symmetry. Eur J Gastroenterol Hepatol. 1998 Jan;10(1):27-32.
7. Farrington CP. Relative incidence estimation from case series for vaccine safety evaluation. Biometrics. 1995 Mar;51(1):228-35.
8. Hallas J. Evidence of depression provoked by cardiovascular medication: a prescription sequence symmetry analysis. Epidemiology. 1996 Sep;7(5):478-84.
9. Petri H, de Vet HC, Naus J, Urquhart J. Prescription sequence analysis: a new and fast method for assessing certain adverse reactions of prescription drugs in large populations. Stat Med. 1988 Nov;7(11):1171-5.
10. Tsiropoulos I, Andersen M, Hallas J. Adverse events with use of antiepileptic drugs: a prescription and event symmetry analysis. Pharmacoepidemiol Drug Saf.
2009 Jun;18(6):483-91.
11. Corrao G, Botteri E, Bagnardi V, Zambon A, Carobbio A, Falcone C, et al.
application to the risk of arrhythmia associated with antibacterials.
Pharmacoepidemiol Drug Saf. 2005 Jan;14(1):31-40.
12. Whitaker HJ, Farrington CP, Spiessens B, Musonda P. Tutorial in biostatistics:
the self-controlled case series method. Stat Med. 2006 May 30;25(10):1768-97.
13. Whitaker HJ, Hocine MN, Farrington CP. The methodology of self-controlled case series studies. Stat Methods Med Res. 2009 Feb;18(1):7-26.
14. 厚生労働省. 重篤副作用疾患別対応マニュアル 薬剤惹起性うつ病. 2008.
15. Interferon beta. In: Aronson JK, editor. Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions 15th ed.
Amsterdam: Elsevier B.V.; 2006. p. 1831-8.
16. Interferon alfa. In: Aronson JK, editor. Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions 15th ed.
Amsterdam: Elsevier B.V.; 2006. p. 1793-831.
17. Koro CE, Meyer JM. Atypical antipsychotic therapy and hyperlipidemia: a review.
Essent Psychopharmacol. 2005;6(3):148-57.
18. 一般社団法人日本アレルギー学会. 喘息予防・管理ガイドライン 2012. 東京: 協和 企画; 2012.
19. Stevenson DD, Szczeklik A. Clinical and pathologic perspectives on aspirin sensitivity and asthma. J Allergy Clin Immunol. 2006 Oct;118(4):773-86; quiz 87-8.
20. Hallas J, Gaist D, Bjerrum L. The waiting time distribution as a graphical approach to epidemiologic measures of drug utilization. Epidemiology. 1997 Nov;8(6):666-70.
21. Koro CE, Fedder DO, L'Italien GJ, Weiss S, Magder LS, Kreyenbuhl J, et al. An assessment of the independent effects of olanzapine and risperidone exposure on the risk of hyperlipidemia in schizophrenic patients. Arch Gen Psychiatry. 2002 Nov;59(11):1021-6.
22. Wahab IA, Pratt NL, Kalisch LM, Roughead EE. Comparing time to adverse drug reaction signals in a spontaneous reporting database and a claims database: a case study of rofecoxib-induced myocardial infarction and rosiglitazone-induced heart failure signals in Australia. Drug Saf. 2014 Jan;37(1):53-64.
23.厚生労働省. 重篤副作用疾患別対応マニュアル 非ステロイド性抗炎症薬による喘 息発作. 2005.
24. Whitaker HJ. SELF CONTROLLED CASE SERIES METHOD. 2010 http://statistics.open.ac.uk/sccs/index.htm
（アクセス日：2014年6月6日）
25. Ramsay EN, Pratt NL, Ryan P, Roughead EE. Proton pump inhibitors and the risk of pneumonia: a comparison of cohort and self-controlled case series designs.
BMC Med Res Methodol. 2013 Jun 24;13(1):82.
26. Pratt N, Roughead EE, Ramsay E, Salter A, Ryan P. Risk of hospitalization for hip fracture and pneumonia associated with antipsychotic prescribing in the elderly: a self-controlled case-series analysis in an Australian health care claims database. Drug Saf. 2011 Jul 1;34(7):567-75.
27. Ramsay EN, Roughead EE, Ewald B, Pratt NL, Ryan P. A self-controlled case series to assess the effectiveness of beta blockers for heart failure in reducing hospitalisations in the elderly. BMC Med Res Methodol. 2011;11:106.
28. Pratt NL, Roughead EE, Ramsay E, Salter A, Ryan P. Risk of hospitalization for stroke associated with antipsychotic use in the elderly: a self-controlled case series.
Drugs Aging. 2010 Nov 1;27(11):885-93.
29. Jackson DJ, Sykes A, Mallia P, Johnston SL. Asthma exacerbations: origin, effect, and prevention. J Allergy Clin Immunol. 2011 Dec;128(6):1165-74.
30. Ryan PB, Madigan D, Stang PE, Overhage JM, Racoosin JA, Hartzema AG.
Empirical assessment of methods for risk identification in healthcare data: results from the experiments of the Observational Medical Outcomes Partnership. Stat Med. 2012 Dec 30;31(30):4401-15.
31. Thomsen SF, Kyvik KO, Skadhauge LR, Steffensen I, Backer V. Regular use of non-steroidal anti-inflammatory drugs increases the risk of adult-onset asthma: a population-based follow-up study. Clin Respir J. 2009 Apr;3(2):82-4.
32. Barr RG, Wentowski CC, Curhan GC, Somers SC, Stampfer MJ, Schwartz J, et al. Prospective study of acetaminophen use and newly diagnosed asthma among women. Am J Respir Crit Care Med. 2004 Apr 1;169(7):836-41.
33. Farrington P. Censoring on outcome is not valid in self-controlled case series studies. J Clin Epidemiol. 2013 Dec;66(12):1428-9.
34. Layton D, Shakir SAW. Prescription-Event Monitoring. In: Strom BL, Kimmel SE, Hennessy S, editors. Pharmacoepidemiology 5th ed. West Sussex: A John Wiley & Sons, Ltd. ; 2012. p. 301-30.